Barrett W. Allan

1.1k total citations
11 papers, 905 citations indexed

About

Barrett W. Allan is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Barrett W. Allan has authored 11 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology. Recurrent topics in Barrett W. Allan's work include Epigenetics and DNA Methylation (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and DNA and Nucleic Acid Chemistry (3 papers). Barrett W. Allan is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and DNA and Nucleic Acid Chemistry (3 papers). Barrett W. Allan collaborates with scholars based in United States and United Kingdom. Barrett W. Allan's co-authors include Norbert O. Reich, Joseph Beechem, William Lindstrom, Jirong Lu, Chi-Kin Chow, James E. Wooldridge, Brian K. Link, Holly A. Bina, James Nelson and Victor J. Wroblewski and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemistry.

In The Last Decade

Barrett W. Allan

11 papers receiving 888 citations

Peers

Barrett W. Allan
David I. Hong United States
Helma Pluk Netherlands
Kimberly A. Solomon United States
Sabine Höpner Switzerland
Sara A. Johnson United States
Elisa Pin Sweden
David I. Hong United States
Barrett W. Allan
Citations per year, relative to Barrett W. Allan Barrett W. Allan (= 1×) peers David I. Hong

Countries citing papers authored by Barrett W. Allan

Since Specialization
Citations

This map shows the geographic impact of Barrett W. Allan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barrett W. Allan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barrett W. Allan more than expected).

Fields of papers citing papers by Barrett W. Allan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barrett W. Allan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barrett W. Allan. The network helps show where Barrett W. Allan may publish in the future.

Co-authorship network of co-authors of Barrett W. Allan

This figure shows the co-authorship network connecting the top 25 collaborators of Barrett W. Allan. A scholar is included among the top collaborators of Barrett W. Allan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barrett W. Allan. Barrett W. Allan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Benschop, Robert J., Chi-Kin Chow, Yu Tian, et al.. (2019). Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease. mAbs. 11(6). 1175–1190. 34 indexed citations
2.
Liu, Ling, Kristine Kikly, Jirong Lu, et al.. (2016). Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A. Journal of Inflammation Research. 9. 39–39. 172 indexed citations
3.
Chow, Chi-Kin, Barrett W. Allan, Qing Chai, S. Atwell, & Jirong Lu. (2016). Therapeutic Antibody Engineering To Improve Viscosity and Phase Separation Guided by Crystal Structure. Molecular Pharmaceutics. 13(3). 915–923. 54 indexed citations
4.
Benschop, Robert J., Emily C. Collins, Ryan J. Darling, et al.. (2014). Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain. Osteoarthritis and Cartilage. 22(4). 578–585. 100 indexed citations
5.
Forero‐Torres, Andres, Sven de Vos, Brad Pohlman, et al.. (2012). Results of a Phase 1 Study of AME-133v (LY2469298), an Fc-Engineered Humanized Monoclonal Anti-CD20 Antibody, in FcγRIIIa-Genotyped Patients with Previously Treated Follicular Lymphoma. Clinical Cancer Research. 18(5). 1395–1403. 54 indexed citations
6.
Bowles, J. A., Siao‐Yi Wang, Brian K. Link, et al.. (2006). Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab. Blood. 108(8). 2648–2654. 171 indexed citations
7.
Breitmeyer, James B., Mary Ann Campbell, Barrett W. Allan, et al.. (2004). AME-133: A Next-Generation Anti-CD20 Engineered for Enhanced Killer Function. Journal of Immunotherapy. 27(6). S52–S52. 2 indexed citations
8.
Allan, Barrett W., Ricardo Garcı́a, Karen A. Maegley, et al.. (1999). DNA Bending by EcoRI DNA Methyltransferase Accelerates Base Flipping but Compromises Specificity. Journal of Biological Chemistry. 274(27). 19269–19275. 40 indexed citations
9.
Allan, Barrett W., Norbert O. Reich, & Joseph Beechem. (1999). Measurement of the Absolute Temporal Coupling between DNA Binding and Base Flipping. Biochemistry. 38(17). 5308–5314. 73 indexed citations
10.
Allan, Barrett W., Joseph Beechem, William Lindstrom, & Norbert O. Reich. (1998). Direct Real Time Observation of Base Flipping by theEcoRI DNA Methyltransferase. Journal of Biological Chemistry. 273(4). 2368–2373. 88 indexed citations
11.
Allan, Barrett W. & Norbert O. Reich. (1996). Targeted Base Stacking Disruption by the EcoRI DNA Methyltransferase. Biochemistry. 35(47). 14757–14762. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026